Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan

Indian Journal of Surgical Oncology

Volumn 2, Issue 2, 2011, Pages 118-121

  Inamdar, Padmanabh ^a   Mehta, Garima ^a  

^a RNT MEDICAL COLLEGE   (India)

Author keywords

Body mass index; Breast cancer; High density lipoprotein cholesterol; Obesity; Waist hip ratio

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER PATIENT; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HIP CIRCUMFERENCE; HUMAN; INDIA; MENOPAUSE; OBESITY; PILOT STUDY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT HEIGHT RATIO;

EID: 84871337342     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-011-0070-x     Document Type: Article

References (23)

1. WHO expert consultaion (2004) Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 157-163.
2. Expert Panel on Detection (2001) Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285(19): 2486-2497.
3. van den BA, Speigelman D, Yaun SS et al (2000) Pooled analysis of prospective cohort studies on height, weight and breast cancer risk. Am J Epidemiol 152: 514-27.
4. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-91.
5. The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94: 606-16.
6. Song YM, Sung J, Ha M (2008) Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26: 3395-402.
7. Sanderson M, Shu XO, Jin F et al (2002) Weight at birth and adolescence and premenopausal breast cancer risk in a low-risk population. Br J Cancer 86: 84-8.
8. Weiderpass E, Braaten T, Magnusson C et al (2004) A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13: 112-7.
9. Pike MC, Spicer DV, Dahmoush L et al (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-30.
10. Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89: 2583-9.
11. Kucharska-Newton AM, Rosamond WD, Mink PJ et al (2008) HDLcholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 18: 671-7.
12. Moorman PG, Hulka BS, Hiatt RA et al (1998) Association between highdensity lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 7: 483-8.
13. Agurs-Collins T, Kim KS, Dunston GM et al (1998) Plasma lipid alterations in African-American women with breast cancer. J Cancer Res Clin Oncol 124: 186-90.
14. Michalaki V, Koutroulis G, Syrigos K et al (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268: 19-24.
15. Gaard M, Tretli S, Urdal P (1994) Risk of breast cancer in relation to blood lipids: a prospective study of 31, 209 Norwegian women. Cancer Causes Control 5: 501-9.
16. Ferraroni M, Gerber M, Decarli A et al (1993) HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol 22: 772-80.
17. Ray G, Husain SA (2001) Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34: 71-6.
18. Furberg AS, Veierod MB, Wilsgaard T et al (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96: 1152-60.
19. Hoyer AP, Engholm G (1992) Serum lipids and breast cancer risk: a cohort study of 5, 207 Danish women. Cancer Causes Control 3: 403-8.
20. Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26: 575-81.
21. Bani IA, Williams CM, Boulter PS, Dickerson JW (1986) Plasma lipids and prolactin in patients with breast cancer. Br J Cancer 54: 439-46.
22. Kokoglu E, Karaarslan I, Karaarslan HM, Baloglu H (1994) Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett 82: 175-8.
23. Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL (1999) Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int 47: 681-90.